Judah Frommer
Stock Analyst at Morgan Stanley
(3.05)
# 472
Out of 5,356 analysts
193
Total ratings
60.00%
Success rate
35.39%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BPMC Blueprint Medicines | Maintains: Equal-Weight | 102 129 | 127.86 | 0.89% | 2 | Jun 5, 2025 | |
CLDX Celldex Therapeutics | Maintains: Overweight | 46 43 | 19.52 | 120.29% | 2 | May 9, 2025 | |
ABVX Abivax | Assumes: Equal-Weight | 12 | 8.13 | 47.6% | 1 | Mar 20, 2025 | |
RGNX Regenxbio | Maintains: Overweight | 22 24 | 8.47 | 183.35% | 2 | Mar 14, 2025 | |
GLPG Galapagos | Downgrades: Underweight | 31 22 | 27.96 | -21.32% | 3 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 6 | 3.88 | 54.64% | 2 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 31 | 19.11 | 62.22% | 1 | Nov 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 81 106 | 66.33 | 59.81% | 2 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 11.07 | 216.17% | 1 | Oct 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 2.58 | 403.88% | 1 | Apr 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 3 | 0.78 | 284.62% | 1 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 40 | 5.66 | 606.71% | 8 | Aug 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 4 | n/a | n/a | 3 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | 1.07 | 1114.95% | 5 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 30 | 35.69 | -15.94% | 8 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 23 | 10.91 | 110.82% | 5 | Aug 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 50 | 51.76 | -3.4% | 9 | Jul 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 141 | 39.13 | 260.34% | 13 | Jun 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | 1.3 | 900% | 5 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 9 | 2.46 | 265.85% | 5 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 175 138 | n/a | n/a | 6 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 21 22 | 19.51 | 12.76% | 2 | Apr 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 5.58 | 25.45% | 3 | Mar 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 1 | n/a | n/a | 4 | Mar 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 8 | 7.11 | 12.52% | 5 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 12.9 | 256.59% | 5 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 7 | 1.16 | 503.45% | 6 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 51 55 | 16.77 | 227.97% | 3 | Feb 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 72.72 | -36.74% | 1 | Feb 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 4 4 | n/a | n/a | 1 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 10 | n/a | n/a | 2 | Oct 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 47 49 | 87.71 | -44.13% | 4 | Nov 5, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 328 370 | 1010.29 | -63.38% | 2 | Oct 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 31 | 77.53 | -60.02% | 6 | Sep 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 65 76 | 73.72 | 3.09% | 8 | Sep 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 182 | 113.82 | 59.9% | 6 | Aug 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 107 | 96.62 | 10.74% | 13 | Aug 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 90 95 | 114.94 | -17.35% | 10 | Jul 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 18 | 21.55 | -16.47% | 1 | Jul 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 93 116 | 127.78 | -9.22% | 12 | Jun 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 38 | 108.94 | -65.12% | 4 | May 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 22 | 167.98 | -86.9% | 1 | May 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 33 35 | 66.11 | -47.06% | 9 | Apr 29, 2020 |